Martin Shkreli, the “pharma bro” entrepreneur who astronomically increased the price of a life-saving drug by more than 4,000 percent and became a symbol of corporate Wall Street greed, cannot return to the pharmaceutical industry, a court has ruled.
COVID-19 Social Distancing Was Not Based On Scientific Data, Fauci Admits